Inc. (AMZN) Is Not About Profits: Bezos

Page 1 of 2 Inc. (NASDAQ:AMZN) has continued to grow at an impressive rate, and has become the juggernaut in e-commerce. The company has provided online convenience, efficient delivery and of course, rock-bottom prices. How in the world does the company provide such low prices for its products and services, and continue to generate buzz among investors or potential investors in the company’s stock? (NASDAQ:AMZN), The Washington Post (NYSE:WPO), Berkshire Hathaway Inc. (NYSE:BRK.A), Apple Inc. (NASDAQ:AAPL)

As Inc. (NASDAQ:AMZN) CEO Jeff Bezos admitted in a recent interview, his business model is not about profits. While that may be no surprise with consumers, how would investors flock to the stock when profits are not the ultimate goal?

It’s all about the Benjamins.

“Percentage margins are not one of the things we are seeking to optimize,” Bezos said to the Harvard Business Review.  “It’s the absolute dollar free cash flow per share that you want to maximize. If you can do that by lowering margins, we would do that. Free cash flow, that’s something investors can spend.”

What does this mean? Free cash is what comes after capital expenditures are subtracted from cash from operations. He believes that the big payoff is not about profits, but it’s about having the cash available to reinvest in the company. Bezos has made it his mission in running the company to have very small margins for a couple of reasons. First, the e-commerce market is a last frontier with a lot of territory still up for grabs. One estimate in a report by Morgan Stanley has the e-commerce marketplace increasing to $1 trillion by 2016, and Inc. (NASDAQ:AMZN) is predicted to occupy about one-fourth of that land area. And part of being able to claim that much market is to provide the best prices to customers so they will more likely go to first for all future purchases – whether they be products or services.

What is the second reason for this model?

Page 1 of 2

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!